BRPI0418126A - método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles - Google Patents

método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles

Info

Publication number
BRPI0418126A
BRPI0418126A BRPI0418126-3A BRPI0418126A BRPI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A BR PI0418126 A BRPI0418126 A BR PI0418126A
Authority
BR
Brazil
Prior art keywords
vaccine
antigens
control
serological diagnosis
determination
Prior art date
Application number
BRPI0418126-3A
Other languages
English (en)
Inventor
Claude Escorguel
Original Assignee
Inodiag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0315327A external-priority patent/FR2864624A1/fr
Priority claimed from FR0408600A external-priority patent/FR2874093B1/fr
Application filed by Inodiag filed Critical Inodiag
Publication of BRPI0418126A publication Critical patent/BRPI0418126A/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Testing Of Engines (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

"MéTODO DE DIAGNóSTICO SOROLóGICO E DETERMINAçãO DE ESTATUTO VACINAL, COMPREENDENDO DIFERENTES CONTROLES". A presente invenção tem por objeto um método de diagnóstico sorológico por imunofluorescência indireta, compreendendo o controle sistemático da presença de fatores reumatóides e de anticorpos anti-nucleares em um soro de paciente, bem como o controle da presença e reatividade dos anticorpos secundários de detecção anti IgM e anti IgG utilizado. De acordo com a presente invenção, uma pluralidade de antígenos microbianos corpusculares e de antígenos de controle, que compreendem imunoglobulinas não específicas IgG e IgM e células nucleadas, são depositados por um robó e fixados por adsorção física sobre esse suporte sólido. A presente invenção se refere igualmente a um método de determinação do estatuto vacinal de um indivíduo por dosagem dos anticorpos de tipo IgG específicos de antígenos vacinais e isto para uma pluralidade de antígenos vacinais, segundo o método de diagnóstico, de acordo com a presente invenção.
BRPI0418126-3A 2003-12-24 2004-12-23 método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles BRPI0418126A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0315327A FR2864624A1 (fr) 2003-12-24 2003-12-24 Methode de diagnostic serologique des maladies infectieuses par immunodetection d'antigene microbien comprenant le controle de reaction faussement positive ou negative
FR0408600A FR2874093B1 (fr) 2004-08-03 2004-08-03 Methode et trousse de determination du statut vaccinal de personnes
PCT/FR2004/003364 WO2005064340A2 (fr) 2003-12-24 2004-12-23 Methode de diagnostic serologique et determination de statut vaccinal comprenant differents controles

Publications (1)

Publication Number Publication Date
BRPI0418126A true BRPI0418126A (pt) 2007-04-10

Family

ID=34740714

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0418126-3A BRPI0418126A (pt) 2003-12-24 2004-12-23 método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles

Country Status (6)

Country Link
US (1) US20070160978A1 (pt)
EP (1) EP1700128B1 (pt)
AT (1) ATE439594T1 (pt)
BR (1) BRPI0418126A (pt)
DE (1) DE602004022588D1 (pt)
WO (1) WO2005064340A2 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006027516B4 (de) * 2006-06-09 2021-10-07 Euroimmun Medizinische Labordiagnostika Ag Verfahren zur Optimierung der automatischen Fluoreszenzmustererkennung in der Immundiagnostik
EP2089689A1 (en) * 2006-11-29 2009-08-19 Laboratorio Celsius S.A. Method for analyzing image data relating to agglutination assays
FR2918459B1 (fr) * 2007-07-04 2009-12-04 Inodiag Methode de diagnostic serologique multiplexe in vitro des infections a spirochetes
RU2472158C1 (ru) * 2011-11-30 2013-01-10 Федеральное государственное Бюджетное учреждение "Государственный научный центр дерматовенерологии и косметологии Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "ГНЦДК" Минздравсоцразвития России) Состав расширенной квалификационной панели контрольных материалов для осуществления внешнего и внутрилабораторного контроля качества серологической диагностики сифилитической инфекции
KR101341994B1 (ko) 2012-02-20 2013-12-16 대한민국 간접면역형광항체법에 의한 레지오넬라증 진단용 항원슬라이드의 제조방법 및 이를 이용한 마이크로 다가 항원슬라이드
CN102692502B (zh) * 2012-04-26 2015-02-04 北京北方生物技术研究所 一种快速检测甲型肝炎病毒IgM抗体的试剂盒及其制备方法
CN113567660A (zh) * 2021-07-22 2021-10-29 中南大学湘雅二医院 一种检测系统性红斑狼疮患者自身抗体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD301364A7 (de) * 1990-04-19 1992-12-10 Berlin Buch Klinikum Verfahren zur Bestimmung von antinukleären Antikörpern
US5478753A (en) * 1993-06-29 1995-12-26 Pb Diagnostic Systems, Inc. Positive calibrator/control composition for an IgM serology assay and an IgM serology assay
DE19731465A1 (de) * 1997-07-22 1999-01-28 Boehringer Mannheim Gmbh Verwendung von Kontrollflächen zur Detektion von Störproben in einem Nachweisverfahren
CA2293677C (en) * 1998-04-14 2009-01-27 Otsuka Pharmaceutical Co., Ltd. Method for assay of antibodies and antibody assay device
RU2213972C1 (ru) * 2002-09-19 2003-10-10 Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова РАМН Способ определения состояния гуморального иммунитета к условно-патогенным бактериям одновременным выявлением igg антител

Also Published As

Publication number Publication date
ATE439594T1 (de) 2009-08-15
DE602004022588D1 (de) 2009-09-24
WO2005064340A2 (fr) 2005-07-14
EP1700128A2 (fr) 2006-09-13
US20070160978A1 (en) 2007-07-12
WO2005064340A3 (fr) 2005-11-24
EP1700128B1 (fr) 2009-08-12

Similar Documents

Publication Publication Date Title
Cerar et al. Humoral immune responses in patients with Lyme neuroborreliosis
Rowntree et al. Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody features
Jurgens et al. Serologic response to mRNA COVID‐19 vaccination in lymphoma patients
Howard et al. Basic methods in antibody production and characterization
CA2589054A1 (en) Detection of a therapeutic antibody in an experimental animal
BRPI0418126A (pt) método de diagnóstico sorológico e determinação de estatuto vacinal, compreendendo diferentes controles
McDowell et al. Evidence that the BBA68 protein (BbCRASP-1) of the Lyme disease spirochetes does not contribute to factor H-mediated immune evasion in humans and other animals
Malik et al. Antibody techniques
CN102965343A (zh) 分泌牛γ干扰素单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用
Chahota et al. Seroprevalence studies on animal chlamydiosis amongst ruminants in five states of India
Day Introduction to antigen and antibody assays
ATE161581T1 (de) Monoklonale antikörper gegen humane pankreas- inselzellen
Smith et al. Local antibody production in experimental pyelonephritis: amount, avidity, and immunoglobulin class
ATE66532T1 (de) Reagenz fuer den nachweis von nicht-a-nicht-bviraler hepatitis und verfahren zur diagnose von solcher hepatitis auf immunoenzymatischem wege.
Alberú et al. A non-allogeneic stimulus triggers the production of de novo HLA antibodies in healthy adults
Sadreddini et al. Evaluation of EBV transformation of human memory B-cells isolated by FACS and MACS techniques
Reincke et al. Antigenic imprinting in SARS‐CoV‐2
Lundgren et al. Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
KR20180020992A (ko) 피검 대상의 검출 방법 및 그것을 위한 면역 측정 기구 및 모노클로널 항체
Gürtürk et al. Detection of Campylobacter Antibodies in Sheep Sera by a Dot‐ELISA Using Acid Extracts from C. fetus ssp. fetus and C. jejuni Strains and Comparison with a Complement Fixation Test
JPH02290556A (ja) 体液等中のレジオネラ抗原の検出方法及び該方法を実施するためのキット
WO2019194360A8 (ko) 개의 수혈 적합성 판별 방법, 및 이를 위한 키트, 단일클론항체 및 하이브리도마 세포주
Wang et al. Anti-gp210-positive primary biliary cholangitis: The dilemma of clinical treatment and emerging mechanisms
Helbig et al. Common epitope on urinary antigen derived from different Legionella pneumophila serogroup 1 strains recognized by a monoclonal antibody
Filippatos et al. SARS-CoV-2 Seroepidemiology and Antibody Levels in Children during BA. 5 Predominance Period

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.